跳至主要内容
临床试验/CTRI/2025/02/080949
CTRI/2025/02/080949尚未招募不适用

Assessment of Glycaemic Index (GI) of DRDC/2024/036

Madras Diabetes Research Foundation1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2025年2月24日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
15
试验地点
1
主要终点
glycemic index (GI) of DRDC/2024/036

研究概览

简要总结

Research studies have shown that lifestyle; in particular dietary aspects play an important role in preventing / increasing the burden of the chronic diseases. Dietary habits could therefore be modified to exert a positive impact in the prevention and treatment. It has been suggested that the high glycemic carbohydrate foods -those foods containing carbohydrates which elicit rapid blood glucose rise and thereby increase the insulin demand leading to hyperinsulinemia, insulin resistance and type 2 diabetes. Hence, there is a need to understand the blood glucose raising potential of foods in India to be of an important tool to aid in the prevention and or management of diabetes and its complication. Thus, evolved the concept of ‘Glycemic Index’ (GI) which ranks the foods, based on the speed at which the food raises the blood glucose in a scale of 0 to 100, 100 indicating high glycemic index corresponds to oral glucose’s GI. Today, India leading the world with the largest number of diabetic participants causing a heavy economic burden to the country urgently needs to look at cost effective strategies to combat this situation. A cost-effective dietary approach like estimating and understanding the role of glycemic index of various Indian foods in the lifestyle related diseases like diabetes is urgently needed.

Aim: To measure glycemic index (GI) of DRDC/2024/036

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Age -18 to 45 years BMI greater than 18.5 to less than 22.9 kg/ m2 (as per WHO cut off for normal BMI) Both male and female Willingness to consume the test foods No known food allergy or intolerance; No medications known to affect glucose tolerance (excluding oral contraceptives) — stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

排除标准

  • A known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions Pregnant or lactating women A major medical or surgical event requiring hospitalization within the preceding 3 months; The presence of disease or drug(s) which influence digestion and absorption of nutrients; The use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).

结局指标

主要结局

glycemic index (GI) of DRDC/2024/036

时间窗: For both intervention and | comparator agents capillary blood samples will | be collected at -5,0 (fasting state) and at | 15,30,45,60,90,120 mins from the first sip of test | and reference foods.

次要结局

未报告次要终点

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr V Mohan

Madras Diabetes Research Foundation

研究点 (1)

Loading locations...

相似试验